PR Newswire - U.S. FDA Granted Priority Review to Dizal's Sunvoz...
If approved, Sunvozertinib as a single oral drug would offer a convenient and safe treatment option with superior efficacy for NSCLC patients with EGFR exon20ins Sunvozertinib's NDA was submit...
Read More

ภาษาไทย
English